Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Sarcoma 1Head & Neck 1Genitourinary 1Endocrine 1CNS 1

Conditions

Prostatic Neoplasms 9Wilms Tumor 2Pancreatic Neoplasms 2Kidney Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pheochromocytoma 1Paraganglioma 1Ovarian Neoplasms 1Neoplastic Syndromes, Hereditary 1Neoplasm Metastasis 1Hepatic Veno-Occlusive Disease 1Genetic Predisposition to Disease 1Colorectal Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Zoledronic Acid 2Vincristine 2Irinotecan 2Gemcitabine 2Etoposide 2Doxorubicin 2Cyclophosphamide 2saracatinib 1robatumumab 1radium Ra 223 dichloride 1liposomal doxorubicin 1cc-486 1Temozolomide 1Taxes 1Standard of Care 1Radiation 1Quality of Life 1Psychology, Positive 1Practice Guidelines as Topic 1Patient Reported Outcome Measures 1Palliative Care 1Paclitaxel 1Observation 1Molecular Diagnostic Techniques 1Methods 1Lomustine 1Injections 1Immunotherapy 1Ifosfamide 1Genetic Testing 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bone Neoplasms × Genetic Testing × Genitourinary × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡